Skip to content

Angi Inc. ANGI Capitalized research & development expenditures

Capitalized research & development expenditures at other companies

Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$39.94M-11.2%
CorMedix logo
CorMedixCRMD
$36.28M
IBT
IbottaIBTA
$22.65M-42.0%
Opko Health logo
Opko HealthOPK
$195M0.0%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$5.17M-73.7%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$752K

Other financials

Income statement

See full
Revenue$238.2M-3.2%
Gross profit$228.5M-1.9%
Operating income-$9.5M-147%
Net income-$9.0M-159%
EPS (diluted)-$0.22-173%

Balance sheet

See full
Cash & equivalents$244.6M-36.7%
Total debt$471.4M-5.2%
Total equity$914.7M-12.8%
Total assets$1.6B-10.0%

Cash flow

See full
Operating cash flow-$17.9M-475%
CapEx$15.7M+25.1%
Free cash flow-$33.6M-114%

Valuation

See full
Market cap$240.67M-67.2%
Enterprise value$467.47M-46.5%
P/E12.2×+0.2×
P/S0.2×-0.4×

Profitability

See full
Gross margin95.7%+0.8pp
Operating margin3.5%0.0pp
Net margin1.9%-2.9pp
FCF margin2.7%-4.4pp

Returns & leverage

See full
Return on equity2%-3.2pp
Debt / equity0.5×0.0×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by Angi Inc. in its filing.

Tagged under the XBRL concept angi:DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures.

The official record: Angi Inc.’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Angi Inc.'s capitalized research & development expenditures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Angi Inc.'s capitalized research & development expenditures?
Angi Inc. (ANGI) reported capitalized research & development expenditures of $2.94M in Q4 2025.
What is the long-term trend for Angi Inc.'s capitalized research & development expenditures?
Over 3 years (2022 to 2025), Angi Inc.'s capitalized research & development expenditures has grown at a -38.3% compound annual growth rate (CAGR), from $12.55M to $2.94M.
What does capitalized research & development expenditures mean?
This reflects the portion of research and development expenditures that have been capitalized rather than expensed immediately. It represents an investment in future product capabilities that will be amortized over time.